Molecular imaging of the breast.
OBJECTIVE
Personalized health care centers around the concept that each tumor and its host environment is unique; optimal treatment and expected response for any given woman presenting with a newly diagnosed breast cancer differ from the care and response of other women.


CONCLUSIONS
As more is understood about the molecular subtypes of breast cancer and as development of targeted therapies progresses, the possibility of earlier treatment response assessment and even improved detection will be realized.
Birdwell
Robyn L
RL
Department of Radiology, Division of Breast Imaging, Brigham and Women's Hospital and Harvard Medical School, 75 Francis St., Boston, MA 02129, USA. rbirdwell@partners.org
Mountford
Carolyn E
CE
Iglehart
J Dirk
JD
D000328:Adult; D000368:Aged; D001706:Biopsy; D001940:Breast / Q000737:chemistry / Q000166:cytology; D001943:Breast Neoplasms / Q000737:chemistry* / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology; D002278:Carcinoma in Situ / Q000737:chemistry / Q000235:genetics / Q000473:pathology; D044584:Carcinoma, Ductal / Q000737:chemistry / Q000235:genetics / Q000473:pathology; D003937:Diagnosis, Differential; D005189:False Positive Reactions; D005260:Female; D005350:Fibroma / Q000175:diagnosis / Q000473:pathology; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008207:Lymphatic Metastasis; D009682:Magnetic Resonance Spectroscopy; D008327:Mammography / Q000379:methods; D008875:Middle Aged; D009362:Neoplasm Metastasis; D020411:Oligonucleotide Array Sequence Analysis; D010641:Phenotype; D049268:Positron-Emission Tomography; D012016:Reference Values